Qelbree OverviewViloxazine, sold under the brand name Qelbree among others, is a medication which is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and depression. It was marketed for more than two decades as an antidepressant in Europe before being repurposed as a treatment for ADHD and launched in the United States in April 2021. Viloxazine is taken by mout...
Read more Qelbree Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Viloxazine
Recent Qelbree Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule, Extended Release: 100mg, 150mg, 200mg
NDC Database Records for Qelbree: (3 results)Sorted by National Drug Code
- 17772-131 Qelbree 100 mg Oral Capsule, Extended Release by Supernus Pharmaceuticals, Inc
- 17772-132 Qelbree 150 mg Oral Capsule, Extended Release by Supernus Pharmaceuticals, Inc
- 17772-133 Qelbree 200 mg Oral Capsule, Extended Release by Supernus Pharmaceuticals, Inc